AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ)
- AbbVie Inc. ABBV 288.50 +1.76%
- Johnson & Johnson JNJ 270.98 +1.45%
AbbVie Inc. and Johnson & Johnson are both Drug Manufacturers General companies. Johnson & Johnson is the larger, with a market value of $650.7B against $501.2B — 1.3× the size. Johnson & Johnson trades at the lower P/E: 40.5× against 48.8×. AbbVie Inc. grew revenue faster over the last twelve months: 10.7% against 7.80%. Johnson & Johnson has the higher net margin (16.2% vs 15.6%) and the lower return on invested capital (11.1% vs 20.2%). Both pay a dividend; AbbVie Inc. yields more (2.44% vs 1.98%). Across the 22 metrics below, AbbVie Inc. leads on 11 and Johnson & Johnson on 11.
Valuation
Profitability
| Metric | ABBV | JNJ | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 73.72% | 67.56% | 73.01% |
| Operating margin | 32.16% | 19.72% | 18.34% |
| Net margin | 15.61% | 16.20% | 7.31% |
| Free cash flow margin | 28.59% | 21.13% | 18.56% |
| Return on equity | (288.69%) | 20.02% | 20.02% |
| Return on assets | 7.32% | 8.25% | 2.28% |
| Return on invested capital | 20.23% | 11.07% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack